Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

BACKGROUND: Metastatic breast cancer (BCa) is most often diagnosed months after completion of treatment of the primary tumor when a patient reports physical symptoms. Besides a physical examination, no other alternative recurrence screening method is recommended for routine follow-up care. Detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Rick L., Pottala, James V., Nagata, Satoshi, Egland, Kristi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793406/
https://www.ncbi.nlm.nih.gov/pubmed/29386014
http://dx.doi.org/10.1186/s12885-018-4022-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793406/
https://www.ncbi.nlm.nih.gov/pubmed/29386014
http://dx.doi.org/10.1186/s12885-018-4022-5

Ejemplares similares